세계의 수술중 신경 모니터링 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Intraoperative Neuromonitoring Market size is anticipated to grow from USD 6.03 Billion in 2024 to USD 10.82 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.72% during the forecast period of 2026 to 2033.

The intraoperative neuromonitoring (IONM) market is experiencing significant growth, driven by the increasing demand for patient safety during surgical procedures and advancements in neuromonitoring technologies. IONM plays a crucial role in minimizing the risk of neurological damage during surgeries, particularly in complex procedures involving the spine, brain, and peripheral nerves. As healthcare providers prioritize patient outcomes, the adoption of IONM is becoming more prevalent, with surgeons and anesthesiologists relying on real-time data to make informed decisions during operations. Innovations in monitoring techniques, such as electromyography (EMG), electroencephalography (EEG), and somatosensory evoked potentials (SSEPs), are enhancing the accuracy and reliability of neuromonitoring, further driving market growth.

Moreover, the increasing prevalence of neurological disorders and the rising number of surgical procedures are propelling the demand for intraoperative neuromonitoring services. As the population ages and the incidence of conditions such as tumors, spinal disorders, and epilepsy rises, the need for effective neuromonitoring solutions becomes more critical. Additionally, the growing emphasis on minimally invasive surgical techniques is contributing to the expansion of the IONM market, as these procedures often require enhanced monitoring to ensure patient safety and optimal outcomes.

Furthermore, the integration of advanced technologies, such as artificial intelligence and machine learning, is transforming the IONM landscape. These technologies enable more sophisticated data analysis and predictive modeling, allowing for improved risk assessment and decision-making during surgeries. The rise of telemedicine and remote monitoring capabilities is also facilitating access to IONM services, enabling healthcare providers to offer expert consultations and support in real-time. In summary, the intraoperative neuromonitoring market is set for robust growth, characterized by technological advancements, a focus on patient safety, and a commitment to improving surgical outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Products and Services

• Systems
• Accessories
• Services

By Source Type

• Insourced Monitoring
• Outsourced Monitoring

By Application

• Spinal Surgery
• Neurosurgery
• Orthopedic Surgery
• ENT Surgery
• Vascular Surgery
• Other surgeries

By Modality

• Motor evoked potentials (MEPs)
• Somatosensory evoked potentials (SSEPs)
• Electroencephalography (EEG)
• Electromyography (EMG)
• Brainstem auditory evoked potentials (BAEPs)
• Visual evoked potentials (VEPs)

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• COMPANIES PROFILED
• Nihon Kohden Corporation
• NeuroStyle Pte.Ltd
• SpecialtyCare
• Intranerve Neuroscience Holdings LLC
• inomed Medizintechnik GmbH
• Medtronic plc
• Natus Medical Incorporated.
• NuVasive Inc.
• Accurate Monitoring
• Computational Diagnostics Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. INTRAOPERATIVE NEUROMONITORING INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Products and Services
  • 3.7.2 Market Attractiveness Analysis By Source Type
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By Modality
  • 3.7.5 Market Attractiveness Analysis By End User
  • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET ANALYSIS BY PRODUCTS AND SERVICES

• 5.1. Overview By Products and Services
• 5.2. Historical and Forecast Data Analysis By Products and Services
• 5.3. Systems Historic and Forecast Sales By Regions
• 5.4. Accessories Historic and Forecast Sales By Regions
• 5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET ANALYSIS BY SOURCE TYPE

• 6.1. Overview By Source Type
• 6.2. Historical and Forecast Data Analysis By Source Type
• 6.3. Insourced Monitoring Historic and Forecast Sales By Regions
• 6.4. Outsourced Monitoring Historic and Forecast Sales By Regions

7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Spinal Surgery Historic and Forecast Sales By Regions
• 7.4. Neurosurgery Historic and Forecast Sales By Regions
• 7.5. Orthopedic Surgery Historic and Forecast Sales By Regions
• 7.6. ENT Surgery Historic and Forecast Sales By Regions
• 7.7. Vascular Surgery Historic and Forecast Sales By Regions
• 7.8. Other Historic and Forecast Sales By Regions

8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET ANALYSIS BY MODALITY

• 8.1. Overview By Modality
• 8.2. Historical and Forecast Data Analysis By Modality
• 8.3. Motor evoked potentials (MEPs) Historic and Forecast Sales By Regions
• 8.4. Somatosensory evoked potentials (SSEPs) Historic and Forecast Sales By Regions
• 8.5. Electroencephalography (EEG) Historic and Forecast Sales By Regions
• 8.6. Electromyography (EMG) Historic and Forecast Sales By Regions
• 8.7. Brainstem auditory evoked potentials (BAEPs) Historic and Forecast Sales By Regions
• 8.8. Visual evoked potentials (VEPs) Historic and Forecast Sales By Regions

9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET ANALYSIS BY END USER

• 9.1. Overview By End User
• 9.2. Historical and Forecast Data Analysis By End User
• 9.3. Hospitals Historic and Forecast Sales By Regions
• 9.4. Ambulatory Surgical Centers (ASCs) Historic and Forecast Sales By Regions

10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2 North America By Segment Sales Analysis
  • 10.3.3 North America By Country Sales Analysis
  • 10.3.4 United States Sales Analysis
  • 10.3.5 Canada Sales Analysis
  • 10.3.6 Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2 Europe By Segment Sales Analysis
  • 10.4.3 Europe By Country Sales Analysis
  • 10.4.4 United Kingdom Sales Analysis
  • 10.4.5 France Sales Analysis
  • 10.4.6 Germany Sales Analysis
  • 10.4.7 Italy Sales Analysis
  • 10.4.8 Russia Sales Analysis
  • 10.4.9 Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2 Asia Pacific By Segment Sales Analysis
  • 10.5.3 Asia Pacific By Country Sales Analysis
  • 10.5.4 China Sales Analysis
  • 10.5.5 India Sales Analysis
  • 10.5.6 Japan Sales Analysis
  • 10.5.7 South Korea Sales Analysis
  • 10.5.8 Australia Sales Analysis
  • 10.5.9 South East Asia Sales Analysis
  • 10.5.10 Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2 Latin America By Segment Sales Analysis
  • 10.6.3 Latin America By Country Sales Analysis
  • 10.6.4 Brazil Sales Analysis
  • 10.6.5 Argentina Sales Analysis
  • 10.6.6 Peru Sales Analysis
  • 10.6.7 Chile Sales Analysis
  • 10.6.8 Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2 Middle East & Africa By Segment Sales Analysis
  • 10.7.3 Middle East & Africa By Country Sales Analysis
  • 10.7.4 Saudi Arabia Sales Analysis
  • 10.7.5 UAE Sales Analysis
  • 10.7.6 Israel Sales Analysis
  • 10.7.7 South Africa Sales Analysis
  • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE INTRAOPERATIVE NEUROMONITORING COMPANIES

• 11.1. Intraoperative Neuromonitoring Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12. COMPANY PROFILES OF INTRAOPERATIVE NEUROMONITORING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Nihon Kohden Corporation
  • 12.3.1 Company Overview
  • 12.3.2 Company Revenue
  • 12.3.3 Products
  • 12.3.4 Recent Developments
• 12.4. NeuroStyle Pte.Ltd
  • 12.4.1 Company Overview
  • 12.4.2 Company Revenue
  • 12.4.3 Products
  • 12.4.4 Recent Developments
• 12.5. SpecialtyCare
  • 12.5.1 Company Overview
  • 12.5.2 Company Revenue
  • 12.5.3 Products
  • 12.5.4 Recent Developments
• 12.6. Intranerve Neuroscience Holdings LLC
  • 12.6.1 Company Overview
  • 12.6.2 Company Revenue
  • 12.6.3 Products
  • 12.6.4 Recent Developments
• 12.7. Inomed Medizintechnik GmbH
  • 12.7.1 Company Overview
  • 12.7.2 Company Revenue
  • 12.7.3 Products
  • 12.7.4 Recent Developments
• 12.8. Medtronic Plc
  • 12.8.1 Company Overview
  • 12.8.2 Company Revenue
  • 12.8.3 Products
  • 12.8.4 Recent Developments
• 12.9. Natus Medical Incorporated.
  • 12.9.1 Company Overview
  • 12.9.2 Company Revenue
  • 12.9.3 Products
  • 12.9.4 Recent Developments
• 12.10. NuVasive Inc.
  • 12.10.1 Company Overview
  • 12.10.2 Company Revenue
  • 12.10.3 Products
  • 12.10.4 Recent Developments
• 12.11. Accurate Monitoring
  • 12.11.1 Company Overview
  • 12.11.2 Company Revenue
  • 12.11.3 Products
  • 12.11.4 Recent Developments
• 12.12. Computational Diagnostics Inc
  • 12.12.1 Company Overview
  • 12.12.2 Company Revenue
  • 12.12.3 Products
  • 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies